Datavault AI Inc. (NASDAQ: DVLT) has expanded its technology licensing partnership with DataMeds AI, Inc. (NASDAQ: MEDS) to encompass the entire spectrum of commercial healthcare, healthspan, and wellness applications, moving beyond its initial focus on pharmaceutical distribution. This strategic amendment positions Datavault AI’s data monetization and real-world asset (RWA) tokenization technologies as a foundational layer for patient-controlled data transactions within the global health sector, which accounts for approximately 30% of worldwide data volume and is growing at an estimated 36% annually.

The amended definitive agreement alters the compensation structure for Datavault AI. The company will now receive common shares representing approximately 19.9% of DataMeds’ common stock upon the closing of related transactions, rather than the previously agreed-upon preferred shares. Management stated this adjustment was implemented to optimize the transaction for tax purposes. The value of these shares is expected to be categorized as revenue for Datavault AI once issued.

Transaction Structure and Closing Conditions

The share issuance to Datavault AI is contingent upon the satisfaction of specific closing conditions tied to concurrent transactions involving DataMeds. These conditions include:

• The acquisition of two QOLPOM intellectual property portfolios from EOS Technology Holdings, Inc.
• The acquisition of a controlling interest in Tollo Health LLC from HighBridge Advisors (referred to as HealthBridge Advisors in the agreement context).

DataMeds is executing these acquisitions in parallel with other entities, including Scilex Holding Company. The expansion of the licensing scope allows Datavault AI’s technology to integrate into DataMeds’ EinsteinRX Platform and PharmacyChain blockchain infrastructure, supporting data valuation and monetization across pharmacy, medical, laboratory, and wearable device settings.

Strategic Rationale and Market Context

Gerald Commissiong, Interim Co-CEO of DataMeds, emphasized that the partnership enables the transformation of data into a strategic asset for customer acquisition and commercial opportunities. "Our business model depends on extracting greater value from the information we generate every day," Commissiong said. "Datavault AI’s platform gives us confidence that we can transform data into a strategic asset... not just for operational insights, but as a foundation for future commercial opportunities."

Nathaniel T. Bradley, CEO of Datavault AI, noted that extending their platform into commercial healthcare is a natural progression for patient-controlled data. "DataMEDS gives us a focused path to put that technology to work so individuals have a say over how their own medical information is transacted," Bradley stated.

What the Numbers Show

The deal targets a significant segment of the global wellness economy, which the Global Wellness Institute valued at $6.8 trillion in 2024 and projects to reach $7.4 trillion in 2025. By integrating with DataMeds, Datavault AI aims to capture value from the rapid expansion of healthcare data, which L.E.K. Consulting estimates grows at a compound annual rate of 36%. The shift from preferred to common equity suggests a focus on long-term alignment and tax efficiency, though it exposes Datavault AI to the same market volatility as public shareholders of DataMeds.

Additional Corporate Developments

DataMeds, formerly known as Wellgistics Health, Inc., completed its corporate name change on July 21, 2026, with trading under the symbol ‘MEDS’ commencing on July 22, 2026. In a separate shareholder initiative, DataMeds announced a dividend of 50 Dream Bowl Meme Coin tokens for each share of common stock held as of the August 7, 2026 record date. This distribution is subject to change at DataMeds’ sole discretion.

Datavault AI Inc. (NASDAQ: DVLT) has signed eight-time All-Star pitcher Dwight "Doc" Gooden as a brand ambassador for its Name, Image, and Likeness exchange platform, now branded as NILX. The agreement, announced on July 27, 2026, positions Gooden to create original promotional content and participate in revenue generated from his likeness on the company’s patented exchange. This addition expands the company’s roster of legacy athletes, following a June 23, 2026, agreement with Darryl Strawberry.

Under the services agreement, Gooden has committed to deliver a minimum of 10 original video works for the platform. He will also engage in promotional activities supporting the exchange. Datavault AI is responsible for providing platform onboarding, operational support, tracking NILX activity attributed to Gooden’s content, and administering revenue share reporting and payments. The partnership aims to demonstrate the platform’s ability to provide measurable and auditable value for public figures outside the collegiate system.

Market Context and Strategic Rationale

The collaboration addresses a gap in the NIL infrastructure, which has primarily focused on collegiate athletes. Datavault AI intends for NILX to serve established public figures who previously lacked mechanisms to retain ongoing value from their name, image, and likeness. Nathaniel T. Bradley, CEO of Datavault AI, noted that Gooden’s career exemplifies the challenge of monetizing likeness rights over time. "Ten original works from him are worth more to this platform than a hundred from someone with no story," Bradley said. "We want athletes to hold generatable, auditable stake in what their name, image and likeness generates."

The broader NIL market is experiencing significant growth. Spending on NIL products and services totaled an estimated $918.0 million in the first year of NIL regulations. According to Opendorse’s "NIL at Four: Monetizing the New Reality" report published in July 2025, the market is projected to reach $2.75 billion in 2025-26 and $3.15 billion by 2028-29. Of the 2025-26 projection, approximately $995 million is attributed to commercial spending by brands and fans, the segment most relevant to Gooden’s role.

Platform Launch and Future Outlook

Gooden joins the platform ahead of its commercial launch. Datavault AI has previously indicated plans to introduce the NIL exchange as part of a suite of specialized data exchange platforms. The company expects to announce additional ambassador and content agreements as the platform advances. The firm operates through its Acoustic Science and Data Science Divisions, leveraging Web 3.0 technologies for data valuation and secure monetization across industries including sports, entertainment, and fintech.

What the Numbers Show

The strategic focus on the commercial segment of the NIL market highlights a shift from collegiate-centric models. With $995 million of the projected $2.75 billion 2025-26 market size driven by brand and fan spending, Datavault AI is positioning NILX to capture value from high-profile figures with established audiences. This approach contrasts with the initial $918.0 million spent in the first year of NIL, suggesting a maturing market where long-term asset management of likeness rights becomes increasingly valuable for legacy athletes.